Please ensure Javascript is enabled for purposes of website accessibility

Why Bausch Health Stock Is Falling Today

By Keith Speights - May 4, 2021 at 11:39AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's mixed Q1 results are partially to blame.

What happened

Shares of Bausch Health Companies (BHC -3.62%) were falling 9.9% lower as of 11:24 a.m. EDT on Tuesday. The decline came after the company announced its first-quarter results before the market opened.

So what

Bausch Health reported Q1 revenue of $2.03 billion, up 1% year over year. That result fell below the consensus Wall Street revenue estimate of $2.06 billion. However, the company's adjusted earnings of $1.04 per share beat the average analyst estimate of $0.94 per share.

Red line with arrow trending down in front of a $100 bill

Image source: Getty Images.

Ordinarily, mixed quarterly results with a narrow revenue miss wouldn't cause a healthcare stock to sink as much as Bausch Health is falling today. Such a decline would make sense if the company's outlook caused reason for alarm. However, Bausch Health reaffirmed its full-year 2021 guidance.

Some investors could be anxious about the planned separation of the company's eye-health business. Bausch Health announced today that current CEO Joseph Papa and incoming CFO Sam Eldessouky will retain their roles in Bausch + Lomb when the company is spun off. In addition, the overall stock market decline is likely weighing on Bausch Health's shares.

Now what

The separation of the company into two businesses is the main thing for investors to look forward to. Bausch Health CEO Joseph Papa said, "We are taking action to accelerate the strategic alternatives process to expedite the spinoff of Bausch + Lomb as we remain committed to unlocking value across our two attractive businesses."

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Bausch Health Companies Inc. Stock Quote
Bausch Health Companies Inc.
$8.51 (-3.62%) $0.32

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.